Effects of Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection on diabetic peripheral neuropathy and oxidative stress response
10.7501/j.issn.0253-2670.2019.11.025
- Author:
Liu LIU
1
Author Information
1. Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University
- Publication Type:Journal Article
- Keywords:
Diabetic peripheral neuropathy;
Mecobalamin;
Nerve conduction velocity;
Oxidative stress response;
Salvia Miltiorrhiza and Ligustrazine Hydrochloride Injection
- From:
Chinese Traditional and Herbal Drugs
2019;50(11):2670-2674
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To study the therapeutic effect of point injection of Salvia Miltiorrhiza and Ligustrazine Hydrochloride Injection (SMLHI) on diabetic peripheral neuropathy (DPN) patients and its effect on oxidative stress response. Methods: A total of 100 DPN patients were selected from the Neurology Department of the Fifth Affiliated Hospital of Zhengzhou University from March 2016 to February 2018. According to the random number table method, the patients were divided into observation group and control group with 50 cases in each group. Each group was treated with routine hypoglycemic drugs, diet control and exercise control, while the control group was treated with Mecobalamin Tablets. The observation group was treated with Mecobalamin Tablets combined with SMLHI at acupoints for 4 weeks as a course of treatment for two consecutive courses of treatment. The clinical symptom score, serum superoxide dismutase (SOD), gamma-glutamyltransferase (GGT), ferritin (SF), total anti-oxidant capacity (T-AOC), and malondialdehyde (MDA) levels, median nerve and peroneal nerve conduction velocity (MNCV), median nerve, peroneal nerve conduction velocity (SNCV), and curative effect were observed and compared before and after treatment. Results: After treatment, the clinical symptom score of the observation group was significantly lower, and the total effective rate of the observation group was 84.00%, which was higher than that of the control group 64.00% (P < 0.05). The SOD level in the observation group was higher, while the GGT, SF, T-AOC, and MDA levels were lower (P < 0.05). The MNCV and SNCV in the observation group were higher (P < 0.05). Conclusion: Acupoint injection of SMLHI for DPN patients can significantly reduce oxidative stress reaction in vivo, promote the recovery of nerve function, improve clinical symptoms of patients with high safety, which is worthy of clinical promotion.
